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Objectives/Hypothesis: High-resolution optical imaging is an imaging modality that allows visualization of structural
changes in epithelial tissue in real time. Our prior studies using contrast-enhanced microendoscopy to image squamous cell
carcinoma in the head and neck demonstrated that the contrast agent, proflavine, has high affinity for keratinized tissue.
Thus, high-resolution microendoscopy with proflavine provides a potential mechanism to identify ectopic keratin production,
such as that associated with cholesteatoma formation, and distinguish between uninvolved mucosa and residual keratin at
the time of surgery.
Study Design: Ex vivo imaging of histopathologically confirmed samples of cholesteatoma and uninvolved middle ear
epithelium.
Methods: Seven separate specimens collected from patients who underwent surgical treatment for cholesteatoma were
imaged ex vivo with the fiberoptic endoscope after surface staining with proflavine. Following imaging, the specimens were
submitted for hematoxylin and eosin staining to allow histopathological correlation.
Results: Cholesteatoma and surrounding middle ear epithelium have distinct imaging characteristics. Keratin-bearing
areas of cholesteatoma lack nuclei and appear as confluent hyperfluorescence, whereas nuclei are easily visualized in speci-
mens containing normal middle ear epithelium. Hyperfluorescence and loss of cellular detail is the imaging hallmark of kera-
tin, allowing for discrimination of cholesteatoma from normal middle ear epithelium.
Conclusions: This study demonstrates the feasibility of high-resolution optical imaging to discriminate cholesteatoma
from uninvolved middle ear mucosa based on the unique staining properties of keratin. Use of real-time imaging may facili-
tate more complete extirpation of cholesteatoma by identifying areas of residual disease.
Key Words: Cholesteatoma, keratin, optical imaging, otology, high-resolution microendoscopy.
Level of Evidence: N/A.
INTRODUCTION
Cholesteatomas are sacs of keratinizing squamous
epithelium that can occur in the middle ear and mastoid.
Cholesteatomas can enlarge, become infected, and cause
local destruction through bony erosion. The only avail-
able treatment for this disease is complete surgical
resection via tympanomastoidectomy.1 However, surgical
treatment is not always curative because regrowth of dis-
ease (recidivism) is relatively common even in experienced
hands, with rates ranging from 5% to 50% in published se-
ries.2–4 Revision surgery is mandatory in these cases, but
this subjects the patient to a second operation and does not
fully assure against further recurrences. Cholesteatoma
recidivism occurs by two different mechanisms: recurrence
is the reformation of an epithelial sac because eustachian
tube dysfunction allows a new retraction pocket to develop,
and residual cholesteatoma is disease left behind by the
surgeon that persists and later regrows. The rate of resid-
ual disease has been reported as high as 30% in some
published series.4 Thus, it is critical to completely remove
all microscopic disease at the initial surgery. To date, there
is no well-established intraoperative imaging device or
technique that can prevent residual disease.
Histologically, cholesteatoma is distinct from the
simple cuboidal or ciliated columnar epithelium lining
the middle ear and mastoid air cells. Cholesteatoma is
comprised of keratinizing squamous epithelium and has
four layers, the same as in skin epidermis, which include
the basal, squamous, granulosum, and stratum corneum,
and which are supported underneath by loose connective
tissue.5,6 These lesions, like skin, shed keratin debris
and stain positive for cytokeratins.7–9
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Optical imaging technologies provide noninvasive
visualization of tissue epithelium in real time.10–12 A
novel endoscopic technique using high-resolution micro-
endoscopy (HRME) allows for the spatial resolution of
individual nuclei and cellular structures.13 The potential
applications of this approach are broad, including the
detection of neoplastic changes in the mucosa of the
head and neck and esophagus.14,15 Our previous studies
using this device to image squamous cell carcinomas in
the head and neck have demonstrated that keratinized
tissue has a high affinity for the contrast agent profla-
vine, thus providing a mechanism to potentially identify
and differentiate cholesteatoma from the surrounding
middle ear epithelium.15,16
In this article, we describe the use of contrast-
enhanced HRME for the detection of cholesteatoma in
the middle ear. The flexible fiberoptic microscope pro-
vides a mechanism to obtain real-time intraoperative
images of tissue epithelium, and is a promising approach
to discriminate between cholesteatoma and surrounding
normal mucosa at the point of care.
MATERIALS AND METHODS
Imaging System
The HRME has been previously described.13 Briefly, the
system consists of a fiberoptic probe, an LED (light-emitting
diode) light source, and a CCD (charge-coupled device) camera
connected to a laptop computer for image capture and storage
(Fig. 1A,B). The fiberoptic probe tip is small and flexible, allow-
ing for access to the middle ear space (Fig. 1C). This imaging
platform is designed for use with proflavine (Sigma-Aldrich, St.
Louis, MO), a fluorescent contrast agent from the acriflavine
family that reversibly binds to DNA and stains cell nuclei.17
Proflavine is buffered with saline to 0.01% solution, and a small
amount is applied topically to tissue epithelium with a cotton-
tipped applicator. Proflavine has been used in in vivo studies of
the gastrointestinal tract in Europe and Australia without any
reported adverse events, and is a component of the dye used to
prevent infection of the umbilical stump of newborns.18–20 Pro-
flavine has never been applied to the middle ear; thus, the
ototoxicity of this agent is currently unknown. Future clinical
studies are therefore required to determine the safety profile for
use in the middle ear.
Specimen Acquisition and Imaging
Through a study protocol approved by the Mount Sinai
School of Medicine Institutional Review Board (GCO# 11-1262),
we obtained seven anonymized surgical specimens of cholestea-
toma, which had been stored at 80C for 1 to 2 years prior to
this study. Specimens were thawed to room temperature prior
to application of proflavine solution (0.01% in saline) to the
specimen with a cotton-tipped applicator and subsequent imag-
ing with the fiberoptic probe (Fig. 1D). The specimens were
then sent for histological processing and preparation of
Fig. 1. (A) Internal configuration of the HRME device. (B) Fiberoptic probe tip. (C) Fiberoptic probe tip delivered to cadaveric temporal bone
after mastoidectomy. (D) Representative cholesteatoma specimen.
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hematoxylin and eosin (H&E) slides correlating with the area
imaged.
Images of the gingiva and head and neck squamous cell
carcinoma specimens were obtained through a study protocol
approved by the Mount Sinai School of Medicine Institutional
Review Board (GCO 09-0954). Grossly normal and malignant
areas of the fresh tumor specimen were stained immediately
with proflavine following standard-of-care surgical resection.
After topical application of the dye, the fiberoptic probe was used
to view these areas and capture images or movie clips of 3-sec-
onds duration. Movie clips were converted to still images using
Windows Movie Maker (Microsoft, Redmond, WA). A 3-mm
punch biopsy of the imaged site was analyzed by conventional
H&E histopathology by a board-certified pathologist.
RESULTS
We could successfully image cholesteatoma and
uninvolved mucosa from all seven specimens. Contrast-
enhanced images of cholesteatoma specimens appeared
as areas of confluent hyperfluorescence that correlated
to histologically confirmed keratin (Fig. 2). The high-re-
solution images of cholesteatoma, composed of mostly
keratin, appeared similar to images from areas of kerati-
nized epithelium in the upper aerodigestive tract
(Fig. 3). Images of middle ear epithelium surrounding
the cholesteatoma displayed obvious normal-appearing
nuclei, which correlated with corresponding histology
(Fig. 4). Therefore, hyperfluorescence and loss of cellular
architecture are the microendoscopic imaging hallmarks
of cholesteatomas due to high keratin composition. The
striking affinity of proflavine for keratin allows straight-
forward differentiation from surrounding middle ear
epithelium, in which nuclei are readily visualized.
DISCUSSION
Here we describe the first report of an optical imag-
ing device applied to otologic surgery. The differences
between cholesteatoma and middle ear epithelium are
readily apparent in the proflavine-enhanced images, pro-
viding a mechanism to ensure elimination of all diseased
tissue. These results support future in vivo intraopera-
tive application of HRME, as the fiberoptic endoscope
can readily be applied during mastoid procedures and
provide real-time imaging that can assist the otologic
surgeon.
The treatment of cholesteatoma is thwarted by the
tendency of the disease to regrow, even after adequate
surgical removal in the most experienced hands. Choles-
teatoma regrowth can be the result of disease recurrence
(the formation of a new sac by invasion of skin from the
external canal into the middle ear), or residual choles-
teatoma (disease unknowingly left behind by the
surgeon).21,22 Cholesteatoma recurrences are associated
Fig. 2. HRME images (left) of cholesteatoma specimens with corresponding H&E appearance at 20 magnification (right). Notice that kera-
tin appears as disorganized hyperfluorescence without visible nuclei.
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with increased morbidity, including the need for addi-
tional surgery, further loss of hearing, recurrent
infection, and potential complications including labyrin-
thitis and intracranial spread.23 Therefore, a mechanism
that could identify residual disease intraoperatively
would be a worthwhile advance in the treatment of this
aggressive disease to reduce the chance of residual
disease.
In our prior studies utilizing HRME for imaging
head and neck squamous cell carcinomas, keratinizing
epithelium appeared hyperfluorescent, which obstructed
visualization of nuclei and was a limitation in
Fig. 3. Appearance of keratin imaged with contrast-enhanced HRME. HRME image (left) of histologically (H&E, original magnification 100)
confirmed (right) keratin from the gingiva of a composite resection of the oral cavity. The arrow indicates a layer of superficial keratin.
Notice that the HRME image shows hyperfluorescence without discrete visualization of nuclei.
Fig. 4. HRME images (left) of middle ear epithelium specimens with corresponding H&E at 20 magnification (right). Nuclei (arrows) are
readily apparent.
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distinguishing benign from cancerous mucosa. Keratin
absorbs proflavine; thus, these contrast-enhanced
images appear as hyperfluorescent. Proflavine, a mem-
ber of the acridine family, is positively charged, and thus
intercalates between negatively charged double-stranded
DNA in a noncovalent manner.24 Although the precise
mechanism of proflavine’s affinity for keratin is not
understood, it may in part be a result of the overall neg-
ative charge of keratin molecules.25,26 Although
hyperkeratosis presents an obstacle to detecting squa-
mous cell carcinoma of the upper aerodigestive tract, for
cholesteatoma, keratin provides the key diagnostic imag-
ing hallmark in HRME images.
This is the first report utilizing the HRME in com-
bination with proflavine on samples that were frozen for
an extended period of time. In our prior head and neck
studies, ex vivo imaging was performed on fresh speci-
mens immediately following surgical resection.13,14,16
Although we have not done a controlled comparison, in
general, we observe that in vivo images show higher
contrast than ex vivo images of fresh or frozen/thawed
tissue. We speculate that the reduction in contrast is
due to partial autolysis that occurs in the ex vivo speci-
mens, resulting in additional cytoplasmic staining.
Nonetheless, the image features otherwise appear quite
similar in the ex vivo and in vivo images despite the
temperature differences. This is true across a wide vari-
ety of organ sites, including oral cavity, breast, uterine
cervix, and esophagus, for which our group has per-
formed both published and ongoing in vivo studies.
In addition to the obvious application of the HRME
to direct in vivo imaging of cholesteatomas to aid in sur-
gical removal, the highly keratinized cholesteatoma
specimens can serve as a platform for further investiga-
tions of the unique imaging properties of keratin,
including its interactions with proflavine, and poten-
tially, other contrast agents. A better understanding of
the imaging properties of keratin and its associated
hyperfluorescence and obstruction of nuclear detail
would improve the utility of HRME for cancer detection
in the upper aerodigestive tract, and potentially allow
application of contrast-enhanced HRME to other highly
keratinized organ systems such as skin.
CONCLUSION
This ex vivo study demonstrates the feasibility of
proflavine-enhanced HRME to distinguish cholesteatoma
from uninvolved middle ear mucosa. Further in vivo
studies are required to test the hypothesis that intrao-
perative real-time imaging can enhance surgical removal
by identifying residual disease, and thereby improve
patient prognosis and surgical outcome.
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